PETMED EXPRESS INC
For the period ended Mar 31, 2024. Filed Jun 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: June 14, 2024
| PETMED EXPRESS, INC. | |
| (the “registrant”) | |
| By: | /s/ Sandra Y. Campos |
| Sandra Y. Campos | |
| Chief Executive Officer and President | |
| (principal executive officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on June 14, 2024.
| SIGNATURE | TITLE |
|---|---|
| /s/ Sandra Y. Campos | Chief Executive Officer, President and Director(principal executive officer) |
| Sandra Y. Campos | |
| /s/ Christine Chambers | Chief Financial Officer and Treasurer(principal financial and accounting officer) |
| Christine Chambers | |
| /s/ Leslie C.G. Campbell | Chair of the Board and Director |
| Leslie C.G. Campbell | |
| /s/ Gian M. Fulgoni | Director |
| Gian M. Fulgoni | |
| /s/ Diana Garvis Purcel | Director |
| Diana Garvis Purcel | |
| /s/ Justin Mennen | Director |
| Justin Mennen | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.